Star Homes Project 2
SHP2
Star Homes - Better Health Through Better Housing: Phase 2 House Evaluation
1 other identifier
interventional
1,183
1 country
1
Brief Summary
Malaria, pneumonia and diarrhoea causes a lot of illness in children in Tanzania and the study want to find better ways of protecting people against these diseases and want to find out if the type of house design can affect the general health of children living in the house.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2020
CompletedFirst Posted
Study publicly available on registry
August 27, 2020
CompletedStudy Start
First participant enrolled
January 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 4, 2026
April 1, 2026
4 years
August 6, 2020
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Incidence of malaria in children under 13 years of age.
The incidence per year of malaria in children under 13 years old.
Approximately 3 years
Incidence of respiratory tract disease in children under 13 years of age.
The incidence per year of respiratory tract disease in children under 13 years old.
Approximately 3 years
Incidence of diarrhoeal disease in children under 13 years of age.
The incidence per year of diarrhoeal disease in children under 13 years old.
Approximately 3 years
Secondary Outcomes (20)
Mean number of female An. gambiae s.l.
Approximately 3 years
Mean number of flies
Approximately 3 years
Entomological inoculation rate of malaria vectors.
Approximately 3 years
Children requiring hospital admission
Approximately 3 years
Major respiratory pathogens
Approximately 3 years
- +15 more secondary outcomes
Study Arms (2)
Arm 1
EXPERIMENTALHouseholds living in novel-design houses.
Arm 2
OTHERHouseholds living in traditional African houses.
Interventions
110 identical novel-designed houses, known as Star Homes, include the critical structural components e.g. building orientated to provide optimal shading throughout the day, light-weight \& durable roof, facade and openings screened from insects to reduce insect entry while assuring airflow, an outdoor fly-proof latrine, and solar power providing electric light at night etc.
A traditional mud house: with wattle and daub walls, a thatched roof, and no electricity or piped water supply.
Eligibility Criteria
You may qualify if:
- Main study
- Children, aged under 13 years old, male or female
- Residing in a study village for at least 3 years
- Parents/guardian is willing and able to give written informed consent for the child to participate in the baseline and end-of study evaluation and the surveillance for malaria, respiratory tract infection and diarrhoeal disease.
- Additionally, children 10, 11, and 12 years of age provide assent to participate.
- Ancillary studies
- Head of a household or other family member of a household that is taking part in the main study
- years and above
- Consent to take part in the main study
- Residing and live in the village for 3 years or more
- Live in the intervention or comparison houses or a trusted community member (community leaders, medical officer and community health worker)
You may not qualify if:
- Main study
- Any participant who refuses, or in the case of children whose parents/guardian refuses, to participate in the study.
- Any child who is between 10 and 12 years who refuses to provide assent
- If the family plans for moving to other village during the study period
- Parents/guardians have mental health problems
- Ancillary studies
- Under 18 years
- Not provide consent
- Not living in the study village for 3 years or more
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- Mahidol Oxford Tropical Medicine Research Unitcollaborator
- CSK Research Solutionscollaborator
Study Sites (1)
CSK Research Solutions
Dar Es Salaam, Mtwara, Tanzania
Related Publications (3)
Mshamu S, Mukaka M, Sanga C, Kambanga S, Rutaihwa AD, Bojstrup TC, Meta J, Mmbando A, Pell C, Adhikari B, Olotu AI, Kapologwe N, White NJ, Dondorp AM, Day NPJ, Imwong M, Deen J, Lindsay SW, Knudsen JB, von Seidlein L. A sustainable house design to improve child health in rural Africa: a cluster-randomized controlled trial. Nat Med. 2026 Apr 21. doi: 10.1038/s41591-026-04367-w. Online ahead of print.
PMID: 42014505RESULTMmbando AS, Ngonzi AJ, Mshamu S, Bradley J, Bojstrup TC, Ngowo HS, Knudsen J, von Seidlein L, Okumu FO, Lindsay SW. Effect of a novel house design (star home) on indoor malaria mosquito abundance in rural Tanzania: secondary outcomes of an open-label, household, randomised controlled trial. Lancet Planet Health. 2025 Apr;9(4):e253-e263. doi: 10.1016/S2542-5196(25)00046-4.
PMID: 40252672DERIVEDMshamu S, Mmbando A, Meta J, Bradley J, Bojstrup TC, Day NPJ, Mukaka M, Okumu F, Olotu A, Pell C, Deen J, Knudsen J, Lindsay SW, von Seidlein L. Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial. Trials. 2022 Jun 20;23(1):519. doi: 10.1186/s13063-022-06461-z.
PMID: 35725486DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lorenz von Seidlein, Ass.Prof.
Mahidol Oxford Tropical Medicine Research Unit
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2020
First Posted
August 27, 2020
Study Start
January 4, 2022
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After completion of trial activities and reporting
- Access Criteria
- MORU Data Sharing Policy. (http://www.tropmedres.ac/data-sharing-policy)
Data collected for this study will be under the custodianship of MORU. With participant's consent, data from this study may be shared in a de-identified form with other groups or researchers in accordance with the MORU Data Sharing Policy.